{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:58:24Z","timestamp":1778252304211,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.phymed.2020.153426","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T12:40:41Z","timestamp":1606740041000},"page":"153426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["\u03949-Tetrahydrocannabinolic Acid markedly alleviates liver fibrosis and inflammation in mice"],"prefix":"10.1016","volume":"81","author":[{"given":"Beatriz","family":"Carmona-Hidalgo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Gonz\u00e1lez-Mariscal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adela","family":"Garc\u00eda-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda E.","family":"Prados","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Ruiz-Pino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Appendino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Tena-Sempere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.phymed.2020.153426_bib0001","doi-asserted-by":"crossref","first-page":"18625","DOI":"10.1074\/jbc.M702538200","article-title":"Ajulemic acid, a synthetic non psychoactive cannabinoid acid, bound to the ligand binding domain of the human peroxisome proliferator-activated receptor gamma","volume":"282","author":"Ambrosio","year":"2007","journal-title":"The Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/j.phymed.2020.153426_bib0002","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1172\/JCI200524282C1","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.phymed.2020.153426_bib0003","first-page":"11","article-title":"Ganja in Jamaica","volume":"nr 2","author":"Boekhout van Solinge","year":"1996","journal-title":"Amsterdams Drug Tijdschrift"},{"issue":"1","key":"10.1016\/j.phymed.2020.153426_bib0004","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cmet.2015.05.003","article-title":"Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease","volume":"22","author":"B\u00f6rgeson","year":"2015","journal-title":"Cell Metabolism"},{"issue":"3","key":"10.1016\/j.phymed.2020.153426_bib0005","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.4049\/jimmunol.164.3.1364","article-title":"The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses","volume":"164","author":"Clark","year":"2000","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"issue":"1","key":"10.1016\/j.phymed.2020.153426_bib0006","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/can.2019.0024","article-title":"Oral Cannabidiol Does Not Convert to \u03948-THC or \u03949-THC in Humans: A Pharmacokinetic Study in Healthy Subjects","volume":"5","author":"Crippa","year":"2020","journal-title":"Cannabis and Cannabinoid Research"},{"issue":"4","key":"10.1016\/j.phymed.2020.153426_bib0007","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2131\/jts.41.561","article-title":"Mechanisms of CCl4-induced liver fibrosis with combined transcriptomic and proteomic analysis","volume":"41","author":"Dong","year":"2016","journal-title":"Journal of Toxicological Sciences"},{"issue":"2","key":"10.1016\/j.phymed.2020.153426_bib0008","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"7","key":"10.1016\/j.phymed.2020.153426_bib0009","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/gast.2002.33666","article-title":"Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro","volume":"122","author":"Galli","year":"2002","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.phymed.2020.153426_bib0010","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/labinvest.2011.191","article-title":"Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl(4)-induced advanced cirrhosis","volume":"92","author":"Giannone","year":"2012","journal-title":"Laboratory Investigation; a Journal of Technical Methods and Pathology"},{"issue":"12","key":"10.1016\/j.phymed.2020.153426_bib0011","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1039\/C6NP00074F","article-title":"Phytocannabinoids: a unified critical inventory","volume":"33","author":"Hanu\u0161","year":"2016","journal-title":"Natural Product Reports"},{"issue":"1","key":"10.1016\/j.phymed.2020.153426_bib0012","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jep.2007.05.019","article-title":"Cannabis tea revisited: a systematic evaluation of the cannabinoid composition of cannabis tea","volume":"113","author":"Hazekamp","year":"2007","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1016\/j.phymed.2020.153426_bib0013","article-title":"Medicinal gebruik van cannabis","volume":"51","author":"Janse","year":"2004","journal-title":"PHARMO Instituut [Institute for Drug Outcomes Research]"},{"issue":"11","key":"10.1016\/j.phymed.2020.153426_bib0014","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.molmet.2017.08.011","article-title":"Decreasing CB1 receptor signaling in Kupffer cells improves insulin sensitivity in obese mice","volume":"6","author":"Jourdan","year":"2017","journal-title":"Molecular Metabolism"},{"issue":"1\u20132","key":"10.1016\/j.phymed.2020.153426_bib0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4161\/19336918.2014.994901","article-title":"Tenascins in fibrotic disorders-from bench to bedside","volume":"9","author":"Kasprzycka","year":"2015","journal-title":"Cell Adhesion & Migration"},{"key":"10.1016\/j.phymed.2020.153426_bib0016","first-page":"59","article-title":"Isolation of other substances from the leaves of Indian hemp","volume":"6","author":"Krejci","year":"1955","journal-title":"Acta UnivPalacki Olomuc"},{"issue":"16","key":"10.1016\/j.phymed.2020.153426_bib0017","doi-asserted-by":"crossref","first-page":"673","DOI":"10.4254\/wjh.v8.i16.673","article-title":"Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy","volume":"8","author":"Kristiansen","year":"2016","journal-title":"World Journal of Hepatology"},{"issue":"46","key":"10.1016\/j.phymed.2020.153426_bib0018","doi-asserted-by":"crossref","first-page":"35715","DOI":"10.1074\/jbc.M006577200","article-title":"Peroxisome proliferator-activated receptors and hepatic stellate cell activation","volume":"275","author":"Miyahara","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"issue":"23","key":"10.1016\/j.phymed.2020.153426_bib0019","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1111\/bph.14019","article-title":"Tetrahydrocannabinolic acid is a potent PPAR\u03b3 agonist with neuroprotective activity","volume":"174","author":"Nadal","year":"2017","journal-title":"British Journal of Pharmacology"},{"issue":"9","key":"10.1016\/j.phymed.2020.153426_bib0020","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1172\/JCI34827","article-title":"Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice","volume":"118","author":"Osei-Hyiaman","year":"2008","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.phymed.2020.153426_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113693","article-title":"Tetrahydrocannabinolic acid A (THCA) reduces adiposity and prevents metabolic disease caused by diet-induced obesity","volume":"171","author":"Palomares","year":"2020","journal-title":"Biochemical Pharmacology"},{"issue":"17","key":"10.1016\/j.phymed.2020.153426_bib0022","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1111\/bph.15155","article-title":"\u03949-Tetrahydrocannabinolic acid alleviates collagen-induced arthritis: Role of PPAR\u03b3 and CB1 receptors","volume":"177","author":"Palomares","year":"2020","journal-title":"Brtitish Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.phymed.2020.153426_bib0023","doi-asserted-by":"crossref","first-page":"16092","DOI":"10.1038\/s41598-018-34259-0","article-title":"VCE-004.8, A Multitarget Cannabinoquinone, Attenuates Adipogenesis and Prevents Diet-Induced Obesity","volume":"8","author":"Palomares","year":"2018","journal-title":"Scientific Reports"},{"issue":"51","key":"10.1016\/j.phymed.2020.153426_bib0024","doi-asserted-by":"crossref","first-page":"21134","DOI":"10.1073\/pnas.1202906109","article-title":"Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor","volume":"109","author":"Pamplona","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.phymed.2020.153426_bib0025","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1038\/ncomms5834","article-title":"Pharmacological correction of obesity-induced autophagy arrest using calcium channel blockers","volume":"5","author":"Park","year":"2014","journal-title":"Nature Communications"},{"issue":"5","key":"10.1016\/j.phymed.2020.153426_bib0026","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/jlb.66.5.733","article-title":"The peroxisome proliferator-activated receptor (PPARgamma) as a regulator of monocyte\/macrophage function","volume":"66","author":"Ricote","year":"1999","journal-title":"Journal of Leukocyte Biology"},{"issue":"23","key":"10.1016\/j.phymed.2020.153426_bib0027","doi-asserted-by":"crossref","first-page":"16124","DOI":"10.1074\/jbc.M707104200","article-title":"Inhibition of recombinant human T-type calcium channels by Delta9-tetrahydrocannabinol and cannabidiol","volume":"283","author":"Ross","year":"2008","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.phymed.2020.153426_bib0028","doi-asserted-by":"crossref","first-page":"e92515","DOI":"10.1371\/journal.pone.0092515","article-title":"Involvement of the TNF and FasL produced by CD11b Kupffer cells\/macrophages in CCl4-induced acute hepatic injury","volume":"9","author":"Sato","year":"2014","journal-title":"PloS One"},{"issue":"1 Suppl","key":"10.1016\/j.phymed.2020.153426_bib0029","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/0023677215571192","article-title":"The carbon tetrachloride model in mice","volume":"49","author":"Scholten","year":"2015","journal-title":"Laboratory Animals"},{"issue":"6","key":"10.1016\/j.phymed.2020.153426_bib0030","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1053\/j.gastro.2007.03.059","article-title":"Obesity, inflammation, and insulin resistance","volume":"132","author":"Shoelson","year":"2007","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.phymed.2020.153426_bib0031","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nm1421","article-title":"CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis","volume":"12","author":"Teixeira-Clerc","year":"2006","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.phymed.2020.153426_bib0032","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.phymed.2020.153426_bib0033","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00204-015-1543-4","article-title":"Experimental models of liver fibrosis","volume":"90","author":"Yanguas","year":"2016","journal-title":"Archives of Toxicology"},{"key":"10.1016\/j.phymed.2020.153426_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2019.106380","article-title":"Lipoxin A4 inhibited the activation of hepatic stellate cells -T6 cells by modulating profibrotic cytokines and NF-\u03baB signaling pathway","volume":"146","author":"Zhang","year":"2020","journal-title":"Prostaglandins & Other Lipid Mediators"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711320302579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711320302579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:26:28Z","timestamp":1760552788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711320302579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":34,"alternative-id":["S0944711320302579"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2020.153426","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03949-Tetrahydrocannabinolic Acid markedly alleviates liver fibrosis and inflammation in mice","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2020.153426","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153426"}}